Literature DB >> 12954563

Host genetic determinants of Neisseria meningitidis infections.

M Emonts1, J A Hazelzet, R de Groot, P W M Hermans.   

Abstract

The clinical presentation of infections caused by Neisseria meningitidis is highly diverse. Some patients develop meningitis, and others present with sepsis or even septic shock. After invasion of the bloodstream by the bacteria, three main cascade pathways are activated. These are the complement system, the inflammatory response, and the coagulation and fibrinolysis pathway. These pathways do not act independently but are able to interact with each other. Genetic polymorphisms among components of these pathways have been shown to be involved in the susceptibility, severity, and outcome of meningococcal disease. We review knowledge of genetic variations associated with susceptibility to and severity of meningococcal infection. Complement deficiencies and defects in sensing or opsonophagocytic pathways, such as the rare Toll-like receptor 4 single nucleotide polymorphisms (SNPs) and combinations of inefficient variants of Fcgamma-receptors, seem to have the most important role in genetically established susceptibility. Effect on severity has repeatedly been reported for FcgammaRIIa and plasminogen activator inhibitor type 1 (PAI1) polymorphisms. Outcome effects have been confirmed for SNPs in properdin deficiencies, PAI1 and combination of the -511C/T SNP in interleukin 1beta, and the +2018C/T SNP in interleukin RN. Conflicting results are reported for the effect of the -308G/A promoter polymorphism in tumour necrosis factor (TNF) alpha. These differences may reflect discrepancies in group definitions between studies or the influence of additional SNPs in the TNFalpha promoter, which can form haplotypes representing different cytokine production capacity. For several SNPs, the potential effect on susceptibility, severity, or outcome has not yet been confirmed in an independent study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954563     DOI: 10.1016/s1473-3099(03)00740-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  55 in total

1.  Neutrophil-to-lymphocyte ratio in the differential diagnosis of acute bacterial meningitis.

Authors:  A-F A Mentis; M A Kyprianou; A Xirogianni; K Kesanopoulos; G Tzanakaki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-20       Impact factor: 3.267

2.  Disease and Carrier Isolates of Neisseria meningitidis Cause G1 Cell Cycle Arrest in Human Epithelial Cells.

Authors:  Michael von Papen; Wilhelm F Oosthuysen; Jérôme Becam; Heike Claus; Alexandra Schubert-Unkmeir
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

3.  Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin.

Authors:  S Lear; E Eren; J Findlow; R Borrow; D Webster; S Jolles
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

Review 4.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

Review 5.  Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Authors:  David S Stephens
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

Review 6.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

7.  Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms.

Authors:  Anne J Tunbridge; Tania M Stevanin; Margaret Lee; Helen M Marriott; James W B Moir; Robert C Read; David H Dockrell
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 8.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 9.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

10.  Protozoan predation, diversifying selection, and the evolution of antigenic diversity in Salmonella.

Authors:  Hans Wildschutte; David M Wolfe; Aletheia Tamewitz; Jeffrey G Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.